Thanks for including a patient advocate on this important research project! #MMsm #ASH24 #HealthTree #myeloma
It was wonderful to get together in-person with our multi-site team working on the LimiTec trial of limited-duration teclistamab therapy for rel/ref #myeloma at #ASH24! Thanks to Leukemia & Lymphoma Society for supporting our trial! clinicaltrials.gov/study/NCT059... @myelomateacher.bsky.social
December 14, 2024 at 3:22 AM
Thanks for including a patient advocate on this important research project! #MMsm #ASH24 #HealthTree #myeloma
Tri-specific Antibody #SAR442257 in RRMM and Non- Hodgkin Lymphoma
#MMsm #ASH24 #HealthTree #myeloma
youtu.be/7NzP-E9WnRo
#MMsm #ASH24 #HealthTree #myeloma
youtu.be/7NzP-E9WnRo
Tri-specific Antibody SAR442257 in RRMM and Non- Hodgkin Lymphoma | Fredrik Schjesvold | #ASH24
YouTube video by HealthTree Foundation for Multiple Myeloma
youtu.be
December 14, 2024 at 3:47 AM
Tri-specific Antibody #SAR442257 in RRMM and Non- Hodgkin Lymphoma
#MMsm #ASH24 #HealthTree #myeloma
youtu.be/7NzP-E9WnRo
#MMsm #ASH24 #HealthTree #myeloma
youtu.be/7NzP-E9WnRo
Today’s ASH highlight video is on Cevostamab-a fixed duration bispecific antibody that targets FCRH5 youtu.be/kHNBPB1S7QY?... #MMsm #ASH24 #HealthTree #myeloma
Cevostamab, a FcRH5 bispecific antibody, for RRMM | Joshua Richter, MD | #ASH2024
YouTube video by HealthTree Foundation for Multiple Myeloma
youtu.be
December 18, 2024 at 5:15 PM
Today’s ASH highlight video is on Cevostamab-a fixed duration bispecific antibody that targets FCRH5 youtu.be/kHNBPB1S7QY?... #MMsm #ASH24 #HealthTree #myeloma
The HealthTree Cure Hub registry: A patient-centered, multicenter approach to advancing multiple myeloma care - Jorge Arturo Hurtado Martínez et al. @HealthTree #ASCO25 Abst e19569 meetings.asco.org/abstracts-pr... #mmsm
Program Guide – ASCO Meeting Program Guide
meetings.asco.org
May 23, 2025 at 3:30 PM
The HealthTree Cure Hub registry: A patient-centered, multicenter approach to advancing multiple myeloma care - Jorge Arturo Hurtado Martínez et al. @HealthTree #ASCO25 Abst e19569 meetings.asco.org/abstracts-pr... #mmsm
This is blood cancer awareness month. This is an empowering message from the HealthTree Foundation
September 9, 2025 at 8:00 AM
This is blood cancer awareness month. This is an empowering message from the HealthTree Foundation
There is a new CAR on the block and it’s performing exceptionally well. This is one of the many videos that is posted on the @HealthTree for Multiple Myeloma YouTube channel where our ASH coverage will be featured . #MMsm #ASH24 #HealthTree #myeloma
youtu.be/sx89o8X7vvU
youtu.be/sx89o8X7vvU
Phase 1 Study of Antio-cel an Anti-BCMA CAR-T for RRMM | Michael Bishop | #ASH24
YouTube video by HealthTree Foundation for Multiple Myeloma
youtu.be
December 14, 2024 at 3:37 AM
There is a new CAR on the block and it’s performing exceptionally well. This is one of the many videos that is posted on the @HealthTree for Multiple Myeloma YouTube channel where our ASH coverage will be featured . #MMsm #ASH24 #HealthTree #myeloma
youtu.be/sx89o8X7vvU
youtu.be/sx89o8X7vvU
Happy to see patients as influencers at major medical meetings. It is so important to include all perspectives in the conversations. #MMsm #ASH24 #HealthTree #myeloma
December 15, 2024 at 8:49 PM
Happy to see patients as influencers at major medical meetings. It is so important to include all perspectives in the conversations. #MMsm #ASH24 #HealthTree #myeloma
Reaching MRD negativity is the goal of #myeloma treatment. The CoMMander trial used Iberdomide to achieve this in Post-ASCT patients who had residual disease after 100 days. @healthtreeorg.bsky.social #MMSM #ASH24 m.youtube.com/watch?v=MiWM...
Iberdomide Combos Post-ASCT in Myeloma: Eliminating Residual Disease (COMMANDER) |Dr. Costa | #ASH24
YouTube video by HealthTree Foundation for Multiple Myeloma
m.youtube.com
December 15, 2024 at 2:51 AM
Reaching MRD negativity is the goal of #myeloma treatment. The CoMMander trial used Iberdomide to achieve this in Post-ASCT patients who had residual disease after 100 days. @healthtreeorg.bsky.social #MMSM #ASH24 m.youtube.com/watch?v=MiWM...
Here we go! So great to see our amazing HealthTree Coaches Michael Riotto, Valarie Traynham and Tony Newberne crushing it at the #ASHRunWalk! 🏃♀️🏃♂️🔥 Inspiring energy and dedication! #ash24
December 8, 2024 at 5:25 PM
Here we go! So great to see our amazing HealthTree Coaches Michael Riotto, Valarie Traynham and Tony Newberne crushing it at the #ASHRunWalk! 🏃♀️🏃♂️🔥 Inspiring energy and dedication! #ash24
To treat or not to treat (HR-SMM) - Listen to @thanosdimop talk about the results of the Aquila trial #MMsm #ASH24 #HealthTree #myeloma youtu.be/C7f-cTLBBfo
Daratumumab vs Observation in High-Risk SMM (Aquila Study) | Meletios Dimopoulos, MD | #ASH24
YouTube video by HealthTree Foundation for Multiple Myeloma
youtu.be
December 15, 2024 at 3:29 PM
To treat or not to treat (HR-SMM) - Listen to @thanosdimop talk about the results of the Aquila trial #MMsm #ASH24 #HealthTree #myeloma youtu.be/C7f-cTLBBfo
Its always nice to hear from the basic researchers. Their successes in the lab eventually transfer to patient care. Thanks! youtu.be/VHE5-RQJnf8?...
#MMsm #ASH24 #HealthTree #myeloma
#MMsm #ASH24 #HealthTree #myeloma
Beating T-Cell Exhaustion: The Future of Myeloma Care | Marta Chesi & Erin Meermeier | #ASH24
YouTube video by HealthTree Foundation for Multiple Myeloma
youtu.be
December 21, 2024 at 6:57 PM
Its always nice to hear from the basic researchers. Their successes in the lab eventually transfer to patient care. Thanks! youtu.be/VHE5-RQJnf8?...
#MMsm #ASH24 #HealthTree #myeloma
#MMsm #ASH24 #HealthTree #myeloma
HealthTree Foundation Launches New Mobile App to Empower Blood Cancer Patients
www.viv-media.com/infozx-36379...
www.viv-media.com/infozx-36379...
HealthTree Foundation Launches New Mobile App to Empower Blood Cancer Patients
www.viv-media.com
March 11, 2025 at 1:00 PM
HealthTree Foundation Launches New Mobile App to Empower Blood Cancer Patients
www.viv-media.com/infozx-36379...
www.viv-media.com/infozx-36379...
thanks to @healthtreeorg.bsky.social to letting me highlight our work on assessing drivers of disparities in a Chicagoland cohort of patients with myelofibrosis! This work is being driven by @andrewthepalmer.bsky.social!
www.youtube.com/watch?v=Xdph...
www.youtube.com/watch?v=Xdph...
Race, Ethnicity, and Socioeconomics Tied to Disparities in Myelofibrosis | Anand Patel, MD | #ASH24
YouTube video by HealthTree Foundation for Blood Cancers
www.youtube.com
January 15, 2025 at 7:34 PM
thanks to @healthtreeorg.bsky.social to letting me highlight our work on assessing drivers of disparities in a Chicagoland cohort of patients with myelofibrosis! This work is being driven by @andrewthepalmer.bsky.social!
www.youtube.com/watch?v=Xdph...
www.youtube.com/watch?v=Xdph...
HealthTree Foundation Unveils Leif: A Smart AI Assistant for Blood Cancer Patients#USA#Salt_Lake_City#Blood_Cancer#HealthTree_Foundation#Leif
HealthTree Foundation Unveils Leif: A Smart AI Assistant for Blood Cancer Patients
HealthTree Foundation has introduced Leif, an AI assistant aimed at assisting blood cancer patients in accessing critical information quickly and efficiently.
third-news.com
March 18, 2025 at 10:33 PM
HealthTree Foundation Unveils Leif: A Smart AI Assistant for Blood Cancer Patients#USA#Salt_Lake_City#Blood_Cancer#HealthTree_Foundation#Leif
🔍 What challenges do you face when treating #MDS, #MF, or #CLL? 🔍
Our expert panels will share real-world case discussions and insights on individualizing treatment. From innovative JAKi in MF to BTKi-BCL2i combinations in CLL, these programs will elevate your practice.
💼 HealthTree Foundation
Our expert panels will share real-world case discussions and insights on individualizing treatment. From innovative JAKi in MF to BTKi-BCL2i combinations in CLL, these programs will elevate your practice.
💼 HealthTree Foundation
November 25, 2024 at 2:43 PM
Nexicart-2 in AL amyloidosis
meetings.asco.org/abstracts-pr...
Next-gen HealthTree Cure Hub
meetings.asco.org/abstracts-pr...
And many more great ones. Congrats to everyone and looking forward to seeing you this week at the meeting.
meetings.asco.org/abstracts-pr...
Next-gen HealthTree Cure Hub
meetings.asco.org/abstracts-pr...
And many more great ones. Congrats to everyone and looking forward to seeing you this week at the meeting.
Program Guide – ASCO Meeting Program Guide
meetings.asco.org
May 25, 2025 at 9:06 AM
Nexicart-2 in AL amyloidosis
meetings.asco.org/abstracts-pr...
Next-gen HealthTree Cure Hub
meetings.asco.org/abstracts-pr...
And many more great ones. Congrats to everyone and looking forward to seeing you this week at the meeting.
meetings.asco.org/abstracts-pr...
Next-gen HealthTree Cure Hub
meetings.asco.org/abstracts-pr...
And many more great ones. Congrats to everyone and looking forward to seeing you this week at the meeting.
HealthTree Foundation Unveils Innovative Mobile App for Blood Cancer Patients’ Empowerment#United_States#mobile_app#Salt_Lake_City#Blood_Cancer#HealthTree_Foundation
HealthTree Foundation Unveils Innovative Mobile App for Blood Cancer Patients’ Empowerment
The HealthTree Foundation has launched a new app designed to empower blood cancer patients, providing access to resources, community support, and research participation.
third-news.com
March 10, 2025 at 9:27 PM
HealthTree Foundation Unveils Innovative Mobile App for Blood Cancer Patients’ Empowerment#United_States#mobile_app#Salt_Lake_City#Blood_Cancer#HealthTree_Foundation
Daratumumab vs Lenalidomide As Myeloma Maintenance Therapy | Sridevi Rajeeve, MD | #ASH24 youtu.be/oZfpQWdgiSc?...
Daratumumab vs Lenalidomide As Myeloma Maintenance Therapy | Sridevi Rajeeve, MD | #ASH24
YouTube video by HealthTree Foundation for Multiple Myeloma
youtu.be
December 16, 2024 at 11:00 PM
Daratumumab vs Lenalidomide As Myeloma Maintenance Therapy | Sridevi Rajeeve, MD | #ASH24 youtu.be/oZfpQWdgiSc?...
Great discussion at #ASH24 during the Health Equity Studio session on achieving equity and inclusion in clinical trial enrollment. Important conversations on ensuring diverse patient representation for better outcomes. #HealthEquity #ClinicalTrials #ASH2024 #HealthTree
December 8, 2024 at 12:26 AM
Great discussion at #ASH24 during the Health Equity Studio session on achieving equity and inclusion in clinical trial enrollment. Important conversations on ensuring diverse patient representation for better outcomes. #HealthEquity #ClinicalTrials #ASH2024 #HealthTree
Standing room and some of us sitting on the floor to hear the latest on #CARTs for large B-cell lymphoma. Lots of excitement about how newer cell therapies can be delivered faster to patients with #lymphoma. Great start to #ASH24!!
#HealthTree #bloodcancer #lymsm #hematology
#HealthTree #bloodcancer #lymsm #hematology
December 7, 2024 at 6:55 PM
Standing room and some of us sitting on the floor to hear the latest on #CARTs for large B-cell lymphoma. Lots of excitement about how newer cell therapies can be delivered faster to patients with #lymphoma. Great start to #ASH24!!
#HealthTree #bloodcancer #lymsm #hematology
#HealthTree #bloodcancer #lymsm #hematology
Sorry to hear about your husband’s diagnosis. Feel free to reach out for any guidance. I coach newly diagnosed and relapsed patients for HealthTree Foundation.
January 3, 2025 at 8:28 AM
Sorry to hear about your husband’s diagnosis. Feel free to reach out for any guidance. I coach newly diagnosed and relapsed patients for HealthTree Foundation.
📖 Have you ordered your copy of #BloodLines yet? buff.ly/LcKPYHA
Juliet Robertson’s powerful new book explores her experience of living with cancer through poetry. Read more about her story in this interview with The Health Tree: buff.ly/asJ8ukW
@blood-lines.bsky.social @itlworldwide.bsky.social
Juliet Robertson’s powerful new book explores her experience of living with cancer through poetry. Read more about her story in this interview with The Health Tree: buff.ly/asJ8ukW
@blood-lines.bsky.social @itlworldwide.bsky.social
Blood Lines: Juliet Robertson Reflects - HealthTree for Acute Myeloid Leukemia
Juliet Robertson shares how poetry, walking, and reflection help her live meaningfully with AML in her new book Blood Lines.
buff.ly
July 5, 2025 at 9:01 AM
📖 Have you ordered your copy of #BloodLines yet? buff.ly/LcKPYHA
Juliet Robertson’s powerful new book explores her experience of living with cancer through poetry. Read more about her story in this interview with The Health Tree: buff.ly/asJ8ukW
@blood-lines.bsky.social @itlworldwide.bsky.social
Juliet Robertson’s powerful new book explores her experience of living with cancer through poetry. Read more about her story in this interview with The Health Tree: buff.ly/asJ8ukW
@blood-lines.bsky.social @itlworldwide.bsky.social